Escitalopram and fluoxetine are two widely prescribed selective serotonin reuptake inhibitors (SSRIs) used primarily to treat depression and anxiety disorders. Both medications have gained popularity due to their efficacy and generally favorable side effect profiles compared to older antidepressants. The choice between these two drugs often hinges on various factors, including the specific diagnosis, individual patient history, and potential side effects. With mental health issues on the rise globally, understanding the nuances of these medications is becoming increasingly important for both healthcare providers and patients alike. As patients seek effective treatment options, it’s essential to consider not only the mechanisms of action but also the differences in efficacy, side effects,…